Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
Why Codiak BioSciences Shares Are Falling During Tuesday’s Session
Codiak BioSciences Inc (NASDAQ: CDAK) shares are trading lower by 29.4% to $1.18 Tuesday after the company proposed a public offering of common stock and warrants.
Dow Drops More Than 1,000 Points, Akero Therapeutics Shares Spike Higher
U.S. stocks traded sharply lower toward the end of trading, following the release of inflation data for August.
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket
Gainers
Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average price of $2.03 - $2.07.
Core & Main, Planet Labs And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Why Codiak BioSciences Shares Are Nosediving During Monday’s After-Hours Session
Codiak BioSciences Inc (NASDAQ: CDAK) shares are trading lower by 21.6% to $1.31 during Monday's after-hours session after the company proposed a public offering of common stock and warrants. No size was disclosed.
What Else?
